The supply of counterfeit medicines and medical devices is a growing problem worldwide. The World Health Organization (WHO) estimates that up to 1% of medicines available in the developed world are likely to be counterfeit. This figure rises to 10% globally, although in some developing countries they estimate one third of medicines are counterfeit.
The new challenges presenting themselves to the pharmaceutical manufacturing industry include the creation of unique serialization codes for individual products during the production process, the secure high-speed printing and verification of these codes, plus the subsequent efficient storage and retrieval of any of these millions of codes at any point within the lifecycle of a product and beyond.
Serialization is vital in the fight against counterfeiting. To support this strategy, so is the development of web-based labeling and management solutions that help in delivering secure and compliant printing for mass serialisation and data management to enhance existing production lines or provide a complete turnkey solution. Other benefits of serialization include the ability to track product movement throughout the supply chain to help improve efficiency. The need to comply with evolving regulatory and compliance environments, and build confidence in the efficient storage and retrieval of products throughout their lifecycle will become essential.
PRISYM ID and Oracle have joined hands to present a free webinar on Wednesday, May 12, 2010 addressing this very issue. Register today and also receive a free serialization whitepaper! “When serialization could be your answer to global anti-counterfeiting”
……… you can’t afford to miss this session!
